Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Vincken

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Clinica Belgica|December 7, 2021
Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosisStefanie Vincken, Sylvia Verbanck, Shane Hanon, et al.
The European Respiratory Journal|March 2, 2019
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatmentStefanie Vincken, Sylvia Verbanck, Elke De Wachter, et al.
Acta Clinica Belgica|August 25, 2016
Liver cirrhosis and thyroid function: Friend or foe?Stefanie Vincken, Hendrik Reynaert, Johan Schiettecatte, et al.
Acta Clinica Belgica|January 22, 2020
A woman and her breathtaking jewelryDimitri Stylemans, Karolien Vekens, Stefanie Vincken, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 17, 2021
A case of self-limited drug induced liver injury under treatment with elexacaftor/tezacaftor/ivacaftor: When it is worth taking the riskDimitri Stylemans, Silke François, Stefanie Vincken, et al.
Respiratory Medicine|April 10, 2021
The role of FeNO in stable COPD patients with eosinophilic airway inflammationStefanie Vincken, Verbanck Sylvia, Schuermans Daniel, et al.
Acta Clinica Belgica|November 23, 2022
Real-world data on the efficacy and safety of tezacaftor-ivacaftor in adults living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutationStefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Acta Clinica Belgica|October 13, 2018
Pulmonary function patterns and their association with genotype and phenotype in adult cystic fibrosis patientsDimitri Stylemans, Sylvia Verbanck, Stefanie Vincken, et al.
Respiration; International Review of Thoracic Diseases|January 26, 2025
The Proof of the Pudding Is in the Eating: Real-Life Intra- and Extrapulmonary Impact of Elexacaftor/Tezacaftor/IvacaftorStefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Interdisciplinary Neurosurgery : Advanced Techniques and Case Management|August 25, 2020
Encephalitis associated with the SARS-CoV-2 virus: A case reportFenne Vandervorst, Kaat Guldolf, Ilse Peeters, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Clinica Belgica|December 7, 2021
Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosisStefanie Vincken, Sylvia Verbanck, Shane Hanon, et al.
The European Respiratory Journal|March 2, 2019
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatmentStefanie Vincken, Sylvia Verbanck, Elke De Wachter, et al.
Acta Clinica Belgica|August 25, 2016
Liver cirrhosis and thyroid function: Friend or foe?Stefanie Vincken, Hendrik Reynaert, Johan Schiettecatte, et al.
Acta Clinica Belgica|January 22, 2020
A woman and her breathtaking jewelryDimitri Stylemans, Karolien Vekens, Stefanie Vincken, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 17, 2021
A case of self-limited drug induced liver injury under treatment with elexacaftor/tezacaftor/ivacaftor: When it is worth taking the riskDimitri Stylemans, Silke François, Stefanie Vincken, et al.
Respiratory Medicine|April 10, 2021
The role of FeNO in stable COPD patients with eosinophilic airway inflammationStefanie Vincken, Verbanck Sylvia, Schuermans Daniel, et al.
Acta Clinica Belgica|November 23, 2022
Real-world data on the efficacy and safety of tezacaftor-ivacaftor in adults living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutationStefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Acta Clinica Belgica|October 13, 2018
Pulmonary function patterns and their association with genotype and phenotype in adult cystic fibrosis patientsDimitri Stylemans, Sylvia Verbanck, Stefanie Vincken, et al.
Respiration; International Review of Thoracic Diseases|January 26, 2025
The Proof of the Pudding Is in the Eating: Real-Life Intra- and Extrapulmonary Impact of Elexacaftor/Tezacaftor/IvacaftorStefanie Vincken, Sylvia Verbanck, Sue Braun, et al.
Interdisciplinary Neurosurgery : Advanced Techniques and Case Management|August 25, 2020
Encephalitis associated with the SARS-CoV-2 virus: A case reportFenne Vandervorst, Kaat Guldolf, Ilse Peeters, et al.
Pageof 1